kine gradients, like those created by the ligands for the chemoExpression of the fractalkine receptor (CX3CR1) in human kine receptor CCR5, might subsequently guide leukocyte subkidney diseases.
The recruitment of leukocytes toward the site of tissue The large family of chemokines is divided into the (N ϭ 8), focal and segmental glomerulosclerosis (N ϭ 10), four groups of CC, CXC, C and CX3C chemokines [9] .
collapsing glomerulopathy (N ϭ 6), and minimal change disease (N ϭ 6) were studied. Immunohistochemistry was per-
The first two of four conserved cysteine residues in the the first two cysteine residues. It is one of two chemoConclusions. The high number of CX3CR1-positive inkines that is tethered to the cell membrane via a mucin flammatory cells in various disease entities is consistent with stalk [9, 11, 12] . Localized on the endothelial surface, its having a role in the accumulation of intrarenal inflammatory cells, but does not provide evidence of specificity of leukocytes CX3CL1 can function both as a chemoattractant and bearing this receptor for specific types of injury. Other chemo-CD3-positive T cells (predominantly CD8 positive cells), (BSA; Sigma Chemicals, St Louis, MO, USA) or 10% about 79% of CD14 positive monocytes and over 90% non-fat dry milk. After subsequent washing in PBS the of CD16 positive natural killer cells expressed detectable tissue was incubated with the biotinylated secondary anamounts of CX3CR1 [14] . In a model of crescentic glotibody (Vector). For signal amplification the ABC-Elite merulonephritis in Wistar Kyoto rats, CX3CL1 is upreagent (Vector) was used. 3,3Ј-diaminobenzidine with regulated and blockade of CX3CR1 by either a broad nickel enhancement, resulting in a black color product, spectrum chemokine receptor antagonist (vMIP-II) or a served as chromogen. Slides were counterstained with CX3CR1 blocking antibody demonstrated a strong benemethyl green, dehydrated and coverslipped. ficial effect [19, 20] . The distribution of CX3CR1 in hu-A polyclonal rabbit anti-human CX3CR1 antibody man kidney diseases including renal transplant rejection (AB1891; Chemicon International, Temecula, CA, USA) is currently unknown. Therefore, we conducted this was used. In Western blots provided by the company, study on various renal diseases and conditions, which the antibody detects a band of approximately 50 kD, differ in the localization of infiltrating leukocyte subsets, which can be blocked by preabsorption with the immuto describe the expression of CX3CR1 in relation to the nizing peptide. Controls used for this antibody in immuinflammatory infiltrates. In addition we compared the nohistochemistry included omission of the primary antiexpression pattern of CX3CR1 expression with the disbody, substitution of the primary antibody by irrelevant tribution pattern of the chemokine receptor CCR5.
rabbit IgG, and blockade of the signal by preabsorption of the primary antibody with the peptide used for immunization (Chemicon Int.). The antibodies MC5 (estab-METHODS lished and provided by M. Mack) against human CCR5 Material [23] , against human CD3 positive T cells (rabbit anti-A total of 84 formalin-fixed and paraffin-embedded human, A0452; Dako, Carpenteria, CA, USA), and renal specimens were examined. These consisted of fetal against human CD68 positive monocytes/macrophages kidneys (N ϭ 12), normal areas of tumor nephrectomies (monoclonal mouse anti-human, Clone PG-M1; Dako) (N ϭ 4), renal transplant nephrectomies (N ϭ 5), renal have previously been used for immunohistochemistry in transplant biopsies (N ϭ 19), and kidney biopsies from formalin-fixed tissue [22, 24] . patients with crescentic glomerulonephritis (N ϭ 7), membranous nephropathy (N ϭ 7), membranoproliferative glomerulonephritis (N ϭ 8), focal and segmental RESULTS glomerulosclerosis (N ϭ 10), collapsing glomerulopathy Expression of CX3CR1 in glomerular diseases (N ϭ 6), and minimal change disease (N ϭ 6). The renal
To describe the distribution of CX3CR1 positive cells biopsies were from cases studied in the Department of in relation to infiltrating inflammatory cells we studied Pathology, University of Washington (Seattle, WA, three groups of tissue samples, which differ by the pre-USA), and were included in this study after the diagnosdominant sites of tissue infiltration. Well preserved renal tic workup was completed. Normal areas from tumor tissue from tumor nephrectomies and biopsies with mininephrectomies and transplant rejection nephrectomies mal change disease was studied, as an example of a nonwere collected over the years 1998 to 2001. No clinical inflammatory disease without significant tubulointerstidata were available for morphological correlations as tial infiltrates. Glomerular diseases that usually show no the approval of the University of Washington internal prominent glomerular inflammatory cell influx, but that review board for human subjects prescribes that no pamay have variable amounts of tubulointerstitial infiltient identifiers may be linked to studies involving netrates and fibrosis depending on the disease stage, are phrectomy or biopsy tissue.
represented by membranous nephropathy, focal and segmental glomerulosclerosis and collapsing glomerulopaImmunohistochemistry thy. Crescentic glomerulonephritis and mesangioproliThe protocols for immunohistochemistry have preferative glomerulonephritis (MPGN) are glomerular viously been described in detail [21, 22] . In brief, from diseases that commonly show prominent glomerular each specimen serial sections were cut at 4 m. Sections macrophage influx and, with disease progression, typiwere deparaffinized and rehydrated. Endogenous peroxcally demonstrate interstitial inflammatory infiltrates and idases were blocked by hydrogen peroxide and antigen fibrosis. Specimens were stained with hematoxylin and retrieval was performed by microwave treatment in Aneosin (H&E), and by immunohistochemistry for CD3-tigen Unmasking Solution (Vector, Burlingame, CA, positive T cells, CD68-positive monocyte/macrophages, USA). Endogenous biotin was blocked using the Avidin/ and the chemokine receptors CX3CR1 and CCR5. SubstiBiotin Blocking Kit (Vector). Primary antibodies were tution of irrelevant rabbit IgG for the primary detecting applied for one hour, diluted either in phosphate-buffered saline (PBS) containing 1% bovine serum albumin antisera, and preabsorption of the primary antisera with the peptide used for immunization, served as negative outnumbered by CD68 positive monocyte/macrophages and CX3CR1 positive cells. CCR5 positive cells princicontrols for CX3CR1 immunolocalization (Fig. 1) .
pally were localized in the tubulointerstitium, consistent In the group of cases from tumor nephrectomies and with our previous studies [23] . Although the percentage minimal change disease, only a small number of CD3-of CCR5-positive infiltrating cells was higher in the interpositive T cells and CD68-positive monocyte/macrostitium as compared to glomeruli, CX3CR1 positive cells phages could be detected in the interstitium. Small numalso outnumbered CCR5 positive cells in the interstitium bers of these cells also could be detected in lumina of (Fig. 3) . In areas of focal T cell infiltrates, there was peritubular and glomerular capillaries ( Fig. 1 and Fig. 2 an overlap in the distribution of CX3CR1 and CCR5, A-C). The distribution of CX3CR1 positive cells mirindicating T cells that expressed both chemokine receprored the combined distribution of these two infiltrating tors (Fig. 3 A, D) . A population of large, round intratucell types. We found no clear evidence for CX3CR1 bular CD68 positive monocyte/macrophages was present expression by intrinsic renal cells, with one exception.
in crescentic glomerulonephritis (Fig. 3 E-G) . These cells Expression of CX3CR1 by intrinsic cells was restricted were almost uniformly positive for CX3CR1, whereas to a single case of allograft rejection in which parietal they were usually CCR5 negative. (Fig. 4 D, E) . Additionally, CX3CR1 cells and the distribution pattern corresponded most to positive cells were present in and around peritubular that of a subset of infiltrating T cells. capillaries (Fig. 4 E, F) . As in glomerular diseases, the Biopsies of crescentic glomerulonephritis (Fig. 2 G-I ) cellular infiltrates were uniformly positive for CX3CR1, and MPGN (Fig. 2 J-L) demonstrated prominent glomerwhereas only a subset was CCR5 positive. ular macrophage influx. On consecutive sections glomerExpression of CX3CR1 during renal development uli demonstrated a similar pattern of CX3CR1 positive cells as compared to the glomerular macrophage distri-A total of 12 fetal kidneys ranging in age from 58 to bution (Fig. 2 H-K) . The number of glomerular CCR5 122 days were studied. CX3CR1 positive cells formed a small, scattered population of cells between developing positive cells was low in both entities and was clearly nephrons and in developing glomeruli (Fig. 5) . These the type of tissue injury, the involved organ, genetic cells did not follow typical patterns of cells forming spefactors of the host and the time course of the insult (acute cific parts of the developing nephron. Furthermore, these vs. chronic). The discovery of the chemokines, functioning cells demonstrated no association with the stage of differas chemoattractants specific for subsets of inflammatory entiation of the developing nephron, nor with the age cells, helped explain an apparent discrepancy between of the kidney. The distribution was consistent with the the previously known chemoattractants that lacked specscattered distribution of CD68 positive cells, although ificities for discrete cell types, and the complexity of we cannot exclude a CX3CR1 expression by a small inflammatory infiltrates [4, 25] . During recent years it subset of stromal cells. CCR5 positive cells were very became apparent that subsets of lymphocytes, monorare in developing kidneys and the number of CD68 cytes and dendritic cells express patterns of different positive cells greatly outnumbered CCR5 positive cells.
chemokine receptors according to their stage of maturation and activation [2] . This enables them to follow simul-DISCUSSION taneous or successive chemotactic gradients in order to migrate toward specific microenvironments [5, 26] . Inflammatory infiltrates are composed of different subsets of infiltrating leukocytes, influenced in part by Experimental data in animal models suggest an impor- tant role of the chemokine-receptor pair of CX3CL1-A recent report localized the expression of CX3CL1 to endothelium of peritubular capillaries but not glomer-CX3CR1 in various inflammatory diseases and make it an attractive target for therapeutic interventions [19, 20] . uli in humans, although this was demonstrated in a very small number of vessels [29] . However, a study by Cock-CX3CL1 is up-regulated during crescentic glomerulonephritis induced in Wistar-Kyoto rats as well as during well et al demonstrated expression of fractalkine in glomeruli, tubular epithelial cells, and peritubular capillarmouse cardiac allograft rejection [19, 27] . The blockade of CX3CR1 demonstrated beneficial effects in both exies in settings of acute crescentic glomerulonephritis or acute renal allograft rejection accompanied by promiperimental systems. However, in contrast to the data obtained in rats with crescentic glomerulonephritis, nent parenchymal infiltration by mononuclear leukocytes, but not in normal kidneys or in biopsies of patients CX3CR1 deficient mice did not demonstrate amelioration of the disease course in nephrotoxic serum nephritis with non-inflammatory diseases such as minimal change disease [30] . This is quite complementary to our finding [28] . Differences in the model system and the types of intervention might account for these results, as specuof leukocytes bearing the appropriate fractalkine receptor in similar disease settings. lated by the authors [28] . CX3CR1 deficient mice demonstrated a significant prolongation of heart transplant sur-CX3CR1 is expressed on the two most common groups of infiltrating cells in inflammatory kidney diseases and vival when treated with low amounts of cyclosporine, whereas untreated mice demonstrated no differences in renal allograft rejection, namely T cells and monocyte/ macrophages [14] . In the current study we dissected the allograft survival as compared to CX3CR1 expressing controls [28] .
patterns of CX3CR1 positive cells by using disease enti- A question that remains unanswered by the present study concerns the rare appearance of CCR5 positive in this study is that the vast majority of cells infiltrating glomeruli as well as all parts of the tubulointerstitium in cells in glomeruli in some inflammatory states. Hypothetically this might be due to differences in ligand convarious kidney diseases seem to be capable of CX3CR1 expression. CX3CR1 expression is not limited to certain centration and/or presentation between glomerular and peritubular endothelium, differences in expression of adsubsets of infiltrating cells or to localization to specialized environments (for example, interstitial vs. glomerular) hesion molecules and their ligands on endothelium of these two compartments, and differences in shear stress. in inflammatory kidney diseases. This is in contrast to our previous findings on two chemokine receptors, CCR2
Recently, the active movement of T cells away from a chemokine has been described [34] . Chemokines might and CCR5, both of which seem to be expressed on specialized subsets of inflammatory cells and are preferennot only recruit subpopulations of inflammatory cells to special microenvironments, but also repulse subsets of tially localized in different renal compartments [22, 23] .
In peripheral blood 13% of CD4-positive T cells, 32% cells from entering other compartments. In summary, our current study as well as correlative of CD8-positive T cells, 7.8% of monocytes, and 4% of natural killer cells were CCR5 positive [31] . CCR5 is animal data imply an important role for CX3CL1-CX3CR1 during renal inflammation. We predict that the expressed by a large subset of tubulointerstitial inflammatory cells, predominantly T cells, but is rarely exeffect of engagement of this receptor by its endothelial bound ligand occurs early during the process of leukopressed by infiltrating cells in glomeruli [23] . CCR2, on the other hand, is commonly expressed by leukocytes cyte extravasation. Mice deficient in either CX3CL1 or CX3CR1 appear to be phenotypically normal, but teminfiltrating glomeruli and its distribution fits best with the distribution of monocytes/macrophages [23] . We now porary blockade of this ligand/receptor system has shown significant beneficial effects in renal injury [35, 36] . Alpresent evidence that CX3CR1 is expressed on both T cells and monocytes/macrophages in renal inflammation.
though the compensatory mechanisms in mice deficient in CX3CL1-CX3CR1 are currently incompletely underIn a study comparing the effects of CX3CR1 and CCR5 blockade, it was found that both approaches showed stood, it raises hopes that therapeutic interventions aimed at this ligand/receptor system in human renal dissignificant benefits but the antagonism of CX3CR1 was superior to CCR5 blockade in ameliorating rat crescentic ease might be safe. glomerulonephritis [19] .
Integrating these data into a working model of renal ACKNOWLEDGMENTS injury, the widespread expression of CX3CR1 at various
